Status:
UNKNOWN
TIGIT in Patients With Chronic Myeloid Leukemia
Lead Sponsor:
Assiut University
Conditions:
Chronic Myeloid Leukemia
Eligibility:
All Genders
Brief Summary
To expresse TIGIT in NK Cells in Patients with Chronic Myeloid Leukemia
Detailed Description
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. In CML, a genetic change takes place...
Eligibility Criteria
Inclusion
- CML patients
- Healthy individuals
Exclusion
- Patients who have current or recent acute infection
- Patients who have autoimmune disease
- Patients who have diabetes mellitus disease
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT04818619
Start Date
April 1 2021
End Date
December 1 2022
Last Update
March 29 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.